FENC
Price
$5.70
Change
+$0.05 (+0.88%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
141.06M
13 days until earnings call
SCPX
Price
$0.07
Change
-$0.06 (-46.15%)
Updated
Apr 21 closing price
Capitalization
393.8K
Ad is loading...

FENC vs SCPX

Header iconFENC vs SCPX Comparison
Open Charts FENC vs SCPXBanner chart's image
Fennec Pharmaceuticals
Price$5.70
Change+$0.05 (+0.88%)
Volume$231
Capitalization141.06M
SCORPIUS HOLDINGS
Price$0.07
Change-$0.06 (-46.15%)
Volume$1.31M
Capitalization393.8K
FENC vs SCPX Comparison Chart
Loading...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FENC vs. SCPX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FENC is a StrongBuy and SCPX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (FENC: $5.69 vs. SCPX: $0.04)
Brand notoriety: FENC and SCPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FENC: 52% vs. SCPX: 52%
Market capitalization -- FENC: $141.06M vs. SCPX: $393.8K
FENC [@Biotechnology] is valued at $141.06M. SCPX’s [@Biotechnology] market capitalization is $393.8K. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FENC’s FA Score shows that 0 FA rating(s) are green whileSCPX’s FA Score has 1 green FA rating(s).

  • FENC’s FA Score: 0 green, 5 red.
  • SCPX’s FA Score: 1 green, 4 red.
According to our system of comparison, SCPX is a better buy in the long-term than FENC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FENC’s TA Score shows that 4 TA indicator(s) are bullish while SCPX’s TA Score has 3 bullish TA indicator(s).

  • FENC’s TA Score: 4 bullish, 6 bearish.
  • SCPX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SCPX is a better buy in the short-term than FENC.

Price Growth

FENC (@Biotechnology) experienced а +12.01% price change this week, while SCPX (@Biotechnology) price change was -67.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

FENC is expected to report earnings on Aug 07, 2025.

SCPX is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FENC($141M) has a higher market cap than SCPX($394K). FENC YTD gains are higher at: -10.601 vs. SCPX (-86.970). FENC has higher annual earnings (EBITDA): 3.02M vs. SCPX (-22.84M). FENC has more cash in the bank: 40.3M vs. SCPX (4.81M). SCPX has less debt than FENC: SCPX (14.9M) vs FENC (32.1M). FENC has higher revenues than SCPX: FENC (49.3M) vs SCPX (10M).
FENCSCPXFENC / SCPX
Capitalization141M394K35,787%
EBITDA3.02M-22.84M-13%
Gain YTD-10.601-86.97012%
P/E Ratio64.14N/A-
Revenue49.3M10M493%
Total Cash40.3M4.81M838%
Total Debt32.1M14.9M215%
FUNDAMENTALS RATINGS
FENC vs SCPX: Fundamental Ratings
FENC
SCPX
OUTLOOK RATING
1..100
5450
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
6298
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCPX's Valuation (8) in the Biotechnology industry is significantly better than the same rating for FENC (90). This means that SCPX’s stock grew significantly faster than FENC’s over the last 12 months.

SCPX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FENC (100). This means that SCPX’s stock grew similarly to FENC’s over the last 12 months.

SCPX's SMR Rating (95) in the Biotechnology industry is in the same range as FENC (100). This means that SCPX’s stock grew similarly to FENC’s over the last 12 months.

FENC's Price Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for SCPX (98). This means that FENC’s stock grew somewhat faster than SCPX’s over the last 12 months.

FENC's P/E Growth Rating (96) in the Biotechnology industry is in the same range as SCPX (100). This means that FENC’s stock grew similarly to SCPX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FENCSCPX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
78%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFLT23.261.49
+6.84%
Confluent
VICR50.672.92
+6.12%
Vicor Corp
HBANP17.580.24
+1.38%
Huntington Bancshares
OCFT6.080.08
+1.33%
OneConnect Financial Technology Co Ltd
AVAH4.540.05
+1.11%
Aveanna Healthcare Holdings

FENC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FENC has been loosely correlated with ATXS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FENC
1D Price
Change %
FENC100%
+3.86%
ATXS - FENC
40%
Loosely correlated
+12.55%
SCPX - FENC
39%
Loosely correlated
+8.78%
BEAM - FENC
38%
Loosely correlated
+3.87%
CLDX - FENC
37%
Loosely correlated
+0.23%
KYMR - FENC
35%
Loosely correlated
+6.56%
More

SCPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPX has been loosely correlated with SPRB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPX
1D Price
Change %
SCPX100%
-8.70%
SPRB - SCPX
43%
Loosely correlated
+5.27%
FENC - SCPX
39%
Loosely correlated
+0.71%
OVID - SCPX
35%
Loosely correlated
+3.63%
BOLT - SCPX
33%
Loosely correlated
+4.57%
CABA - SCPX
33%
Loosely correlated
-5.22%
More